Robert Patrick Giugliano
Brigham and Women's Hospital
3 papers in the Anchorcite directory, published between 2013 and 2017, cited 16,216 times in total.
ORCID profileResearch topics
- Lipoproteins and Cardiovascular Health · 2 papers
- Acute Myocardial Infarction Research · 2 papers
- Atherosclerosis and Cardiovascular Diseases · 1 paper
- Acute Ischemic Stroke Management · 1 paper
- Atrial Fibrillation Management and Outcomes · 1 paper
- Venous Thromboembolism Diagnosis and Management · 1 paper
Frequent co-authors
- Stephen D. Wiviott · 3 papers
- Eugene Braunwald · 2 papers
- Marc Steven Sabatine · 1 paper
- ANTHONY C. KEECH · 1 paper
- Narimon Honarpour · 1 paper
- Sabina A. Murphy · 1 paper
- Julia Kuder · 1 paper
- Huei Wang · 1 paper
Papers
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine · 2017 · 6,357 citations
BACKGROUND: Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving…
- Edoxaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2013 · 5,259 citations
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial…
- Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesNew England Journal of Medicine · 2015 · 4,600 citations
BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known.…
Metadata from OpenAlex (CC0).